OC.15.6 SERUM MICRORNA PREDICT FIBROSIS IN LIVER TRANSPLANT RECIPIENTS WITH HCV RECURRENCE AFTER TREATMENT WITH DAAS: A PILOT STUDY. (May 2022) - Magro, B.; Barbera, F.; Seidita, A.; Tuzzolino, F.; Gruttadauria, S.; Conaldi, P.G.; Pietrosi, G.